Phase I / IIa clinical trial of endoscopic ultrasonographic guidance of the nucleic acid drug STNM01 in patients with drug-resistant unresectable pancreatic cancer (doctor-led clinical trial)
Latest Information Update: 09 Oct 2024
At a glance
- Drugs GUT 1 (Primary) ; Gemcitabine; Gimeracil/oteracil/tegafur; Paclitaxel
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2022 Final PI/IIa results and follow-up clinical results investigating the changes of tumor microenvironmental parameters and the correlation with overall survival, presented at the 58th Annual Meeting of the American Society of Clinical Oncology
- 22 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology